The NIH National Cancer Institute recently awarded our lab with a 5-year $1.76 million R01 research grant for optimization of microbubble dose for blood-brain barrier disruption and treatment of brain cancer and neurological disorders. The research team includes Brandon Harvey at NIDA and Nick Ellens from local ultrasound company Acertera.
